Luteolin treatment has been found to induce apoptosis in Bcl-2 overexpressing SW1990 pancreatic cancer cells via inhibiting Bcl-2 expression in a dose-dependent manner [135]. Here, BCL2 is linked to familial pancreatic carcinoma.